Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
3.2M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
2.5M
-
Shares change
-
+15.7K
-
Total reported value, excl. options
-
$203M
-
Value change
-
+$2.19M
-
Number of buys
-
42
-
Number of sells
-
-26
-
Price
-
$81.40
Significant Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) as of Q4 2017
83 filings reported holding UTMD - UTAH MEDICAL PRODUCTS INC - Common Shares as of Q4 2017.
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.5M shares
of 3.2M outstanding shares and own 77.94% of the company stock.
Largest 10 shareholders include FMR LLC (521K shares), PRICE T ROWE ASSOCIATES INC /MD/ (290K shares), RENAISSANCE TECHNOLOGIES LLC (212K shares), DIMENSIONAL FUND ADVISORS LP (164K shares), Vanguard Group Inc (162K shares), BlackRock Inc. (162K shares), STATE STREET CORP (89.2K shares), WCM INVESTMENT MANAGEMENT/CA (82.3K shares), Russell Investments Group, Ltd. (71.2K shares), and Ancora Advisors, LLC (70.4K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.